WSO - March 2024 - 332

332
International Journal of Stroke 19(3)
Introduction
Though the prevalence of post-stroke cognitive impairment
varies depending on the timing, assessment, and inclusion
criteria, most stroke survivors experience at least one cognitive
deficit.1,2 Identifying which cognitive impairments
more commonly occur, recover, and persist will aid in intervention
planning and setting rehabilitation goals.
Early post-stroke cognitive assessment is recommended
in clinical guidelines and best practice statements.3-6 The
Oxford Cognitive Screen (OCS)7,8 is a short, domain-specific
cognitive screen which compromises between the benefits
of global tests and neuropsychological batteries. The
OCS offers superior patient inclusivity and sensitivity than
brief screens (e.g. the Mini-Mental State Examination
(MMSE) and Montreal Cognitive Assessment (MoCA)).1,9
It also assesses multiple domains much like a neuropsychological
battery, which is in line with clinical guidance.
Acute domain impairments are highly prevalent after
stroke;1 however, the prevalence and trajectories of domainspecific
impairment beyond the acute stage are relatively
unknown. In addition, while the OCS has recently been
shown to provide value information regarding functional
outcomes,10 it has not been established whether the short
screen had prognostic value in determining longer-term
cognitive outcome.
Very few studies have considered acute post-stroke cognitive
performance in longer-term outcome prediction models,
and instead, the focus tends to be on clinical and
neuroimaging markers.11 A few previous studies have aimed
to predict outcomes using brief global screens12 (e.g. the
MoCA).13-17 Acute MoCA scores predict long-term cognitive
and functional outcome, and mortality.13 However, the
MoCA is not always suitable for stroke as it assumes cognitive
functions (e.g. speech, vision) are intact. Consequently,
common post-stroke impairments (e.g. aphasia, neglect) can
confound assessment.9,12
One study used a multi-domain neuropsychological battery
to investigate the prognostic value of early cognitive
assessment18,19 and found acute performance to predict
6-month cognitive and functional outcome better than
demographic or clinical variables.19 These findings support
the utility of cognitive data; however, a large neuropsychological
battery (>1 h) is typically not feasible in routine
acute clinical practice due to time requirements and
increased burden on the patient, as well as staff availability
and expertise.
This study aimed to use the OCS to (1) determine the
prevalence of domain-specific cognitive impairments
acutely and at 6 months post-stroke, (2) assess change in
function across timepoints, and (3) examine the predictive
value of early domain-specific screening. Importantly, this
study does not aim to build optimal prognostic models
employing all potential predictors (e.g. genetic risk) but
instead aims to determine the value added by considering
International Journal of Stroke, 19(3)
cognitive data. Ultimately, this could lead to practical prognostic
models based on routinely collected and easily
accessible data, promoting informed and efficient clinical
decision-making.
Methods
This study considered existing data from the OCS-Tablet
and OCS-Recovery studies (National Research Ethics
Committee (UK), references 14/LO/0648 and 18/
SC/0550, in accordance with the Declaration of Helsinki).
Patients (⩾18 years old) were included if they could provide
written/witnessed informed consent, could concentrate
for 20 min, and had sufficient English language
comprehension.
Participants
A consecutive sample of acute stroke patients was recruited
from the John Radcliffe Hospital, UK, acute stroke unit
(2012-2019). In total, 866 patients were assessed acutely
(⩽2 weeks), with 430 (49.7%) completing 6-month followup
(Figure 1).
Cognitive assessment
The OCS was used for acute and follow-up cognitive
screening.7 The OCS covers a broad range of cognitive
domains and was designed specifically for use in acute
stroke taking 15-20 min to complete. Subtests are categorized
into six domains: language (picture naming, semantic
understanding, and sentence reading), attention (egocentric
and allocentric attention; broken hearts test), executive
function (trail-making test), memory (orientation, verbal,
and episodic memory; delayed recall/recognition), praxis
(meaningless gesture imitation), and number processing
(calculations and number writing). Each task has a threshold
cut-off to indicate impairment based on published normative
data.7,8 Subtests were binarized into impaired or
unimpaired based on normative scores for each subtest.
Domains were considered impaired if there is at least one
subtest in the domain (e.g. language impaired if reading,
naming, or semantics impaired). Subtests range from one to
three across domains. The OCS was administered by trained
neuropsychologists and occupational therapists. The OCS
is licensed through Oxford University Innovations free of
charge for publicly funded research and clinical use. Further
information regarding administration of the OCS is detailed
in supplemental methods.
Statistical analysis
Descriptive statistics were used to summarize the prevalence
of cognitive impairment/recovery as cognitive data
were limited to binarized outcome. Associations between

WSO - March 2024

Table of Contents for the Digital Edition of WSO - March 2024

Contents
WSO - March 2024 - Cover1
WSO - March 2024 - Cover2
WSO - March 2024 - 245
WSO - March 2024 - Contents
WSO - March 2024 - 247
WSO - March 2024 - 248
WSO - March 2024 - 249
WSO - March 2024 - 250
WSO - March 2024 - 251
WSO - March 2024 - 252
WSO - March 2024 - 253
WSO - March 2024 - 254
WSO - March 2024 - 255
WSO - March 2024 - 256
WSO - March 2024 - 257
WSO - March 2024 - 258
WSO - March 2024 - 259
WSO - March 2024 - 260
WSO - March 2024 - 261
WSO - March 2024 - 262
WSO - March 2024 - 263
WSO - March 2024 - 264
WSO - March 2024 - 265
WSO - March 2024 - 266
WSO - March 2024 - 267
WSO - March 2024 - 268
WSO - March 2024 - 269
WSO - March 2024 - 270
WSO - March 2024 - 271
WSO - March 2024 - 272
WSO - March 2024 - 273
WSO - March 2024 - 274
WSO - March 2024 - 275
WSO - March 2024 - 276
WSO - March 2024 - 277
WSO - March 2024 - 278
WSO - March 2024 - 279
WSO - March 2024 - 280
WSO - March 2024 - 281
WSO - March 2024 - 282
WSO - March 2024 - 283
WSO - March 2024 - 284
WSO - March 2024 - 285
WSO - March 2024 - 286
WSO - March 2024 - 287
WSO - March 2024 - 288
WSO - March 2024 - 289
WSO - March 2024 - 290
WSO - March 2024 - 291
WSO - March 2024 - 292
WSO - March 2024 - 293
WSO - March 2024 - 294
WSO - March 2024 - 295
WSO - March 2024 - 296
WSO - March 2024 - 297
WSO - March 2024 - 298
WSO - March 2024 - 299
WSO - March 2024 - 300
WSO - March 2024 - 301
WSO - March 2024 - 302
WSO - March 2024 - 303
WSO - March 2024 - 304
WSO - March 2024 - 305
WSO - March 2024 - 306
WSO - March 2024 - 307
WSO - March 2024 - 308
WSO - March 2024 - 309
WSO - March 2024 - 310
WSO - March 2024 - 311
WSO - March 2024 - 312
WSO - March 2024 - 313
WSO - March 2024 - 314
WSO - March 2024 - 315
WSO - March 2024 - 316
WSO - March 2024 - 317
WSO - March 2024 - 318
WSO - March 2024 - 319
WSO - March 2024 - 320
WSO - March 2024 - 321
WSO - March 2024 - 322
WSO - March 2024 - 323
WSO - March 2024 - 324
WSO - March 2024 - 325
WSO - March 2024 - 326
WSO - March 2024 - 327
WSO - March 2024 - 328
WSO - March 2024 - 329
WSO - March 2024 - 330
WSO - March 2024 - 331
WSO - March 2024 - 332
WSO - March 2024 - 333
WSO - March 2024 - 334
WSO - March 2024 - 335
WSO - March 2024 - 336
WSO - March 2024 - 337
WSO - March 2024 - 338
WSO - March 2024 - 339
WSO - March 2024 - 340
WSO - March 2024 - 341
WSO - March 2024 - 342
WSO - March 2024 - 343
WSO - March 2024 - 344
WSO - March 2024 - 345
WSO - March 2024 - 346
WSO - March 2024 - 347
WSO - March 2024 - 348
WSO - March 2024 - 349
WSO - March 2024 - 350
WSO - March 2024 - 351
WSO - March 2024 - 352
WSO - March 2024 - 353
WSO - March 2024 - 354
WSO - March 2024 - 355
WSO - March 2024 - 356
WSO - March 2024 - 357
WSO - March 2024 - 358
WSO - March 2024 - 359
WSO - March 2024 - 360
WSO - March 2024 - 361
WSO - March 2024 - 362
WSO - March 2024 - 363
WSO - March 2024 - 364
WSO - March 2024 - 365
WSO - March 2024 - 366
WSO - March 2024 - 367
WSO - March 2024 - 368
WSO - March 2024 - 369
WSO - March 2024 - 370
WSO - March 2024 - 371
WSO - March 2024 - 372
WSO - March 2024 - Cover3
WSO - March 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com